Filed: 5/15/2026ACC: 0001799883-26-000002
📋 What this filing means
5AM VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $360.21M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$360.21M
Total AUM (reported)
41.80M
Total Shares
Allocation by class
COM$272.89M75.8%
COM NEW$46.55M12.9%
SPONSORED ADS$23.08M6.4%
ORDINARY SHARES$8.05M2.2%
COM STK$7.14M2.0%
ADS$2.51M0.7%
Portfolio Concentration
Top 3$147.02M40.8%
4–10$140.48M39.0%
11–25$72.71M20.2%
Top 3 weight
40.8%
Top 10 weight
79.8%
Voting Authority Distribution
Total shares with voting rights: 41.80M
Sole
Full voting authority
41.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
ERASCA INC
SOLEShares3.49M
TypeSH
Market value$56.40M
15.66%
Sole
3.49M
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares4.06M
TypeSH
Market value$51.19M
14.21%
Sole
4.06M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.03M
TypeSH
Market value$39.42M
10.94%
Sole
1.03M
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares5.87M
TypeSH
Market value$25.88M
7.19%
Sole
5.87M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares580.95K
TypeSH
Market value$23.08M
6.41%
Sole
580.95K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares797.60K
TypeSH
Market value$22.53M
6.26%
Sole
797.60K
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
SOLEShares950.01K
TypeSH
Market value$19.31M
5.36%
Sole
950.01K
Shared
0.00
None
0.00
TECTONIC THERAPEUTIC INC
SOLEShares606.66K
TypeSH
Market value$18.75M
5.21%
Sole
606.66K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares497.27K
TypeSH
Market value$15.77M
4.38%
Sole
497.27K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares2.35M
TypeSH
Market value$15.16M
4.21%
Sole
2.35M
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares1.05M
TypeSH
Market value$13.53M
3.76%
Sole
1.05M
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares387.50K
TypeSH
Market value$11.29M
3.13%
Sole
387.50K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC
SOLEShares3.95M
TypeSH
Market value$9.24M
2.56%
Sole
3.95M
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares572.66K
TypeSH
Market value$8.05M
2.24%
Sole
572.66K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.37M
TypeSH
Market value$7.14M
1.98%
Sole
1.37M
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares738.97K
TypeSH
Market value$6.25M
1.74%
Sole
738.97K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares3.06M
TypeSH
Market value$6.13M
1.70%
Sole
3.06M
Shared
0.00
None
0.00
SKYE BIOSCIENCE INC
SOLEShares9.68M
TypeSH
Market value$5.95M
1.65%
Sole
9.68M
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares291.79K
TypeSH
Market value$2.62M
0.73%
Sole
291.79K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares476.20K
TypeSH
Market value$2.51M
0.70%
Sole
476.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ERASCA INCSOLE | COM | 3.49M | SH | $56.40M 15.66% | 3.49M | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COM | 4.06M | SH | $51.19M 14.21% | 4.06M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 1.03M | SH | $39.42M 10.94% | 1.03M | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 5.87M | SH | $25.88M 7.19% | 5.87M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 580.95K | SH | $23.08M 6.41% | 580.95K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 797.60K | SH | $22.53M 6.26% | 797.60K | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCSOLE | COM | 950.01K | SH | $19.31M 5.36% | 950.01K | 0.00 | 0.00 |
TECTONIC THERAPEUTIC INCSOLE | COM | 606.66K | SH | $18.75M 5.21% | 606.66K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 497.27K | SH | $15.77M 4.38% | 497.27K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 2.35M | SH | $15.16M 4.21% | 2.35M | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 1.05M | SH | $13.53M 3.76% | 1.05M | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 387.50K | SH | $11.29M 3.13% | 387.50K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 3.95M | SH | $9.24M 2.56% | 3.95M | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 572.66K | SH | $8.05M 2.24% | 572.66K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.37M | SH | $7.14M 1.98% | 1.37M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 738.97K | SH | $6.25M 1.74% | 738.97K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 3.06M | SH | $6.13M 1.70% | 3.06M | 0.00 | 0.00 |
SKYE BIOSCIENCE INCSOLE | COM NEW | 9.68M | SH | $5.95M 1.65% | 9.68M | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 291.79K | SH | $2.62M 0.73% | 291.79K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 476.20K | SH | $2.51M 0.70% | 476.20K | 0.00 | 0.00 |